D Dimer Testing Market Report 2026

D Dimer Testing Market Overview

• D Dimer Testing market size has reached to $1.54 billion in 2025 • Expected to grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Cancer Prevalence Fuels Expansion Of The D-Dimer Testing Market • Market Trend: Innovations in D-Dimer Testing: Enhancements in Diagnostic Accuracy and Speed • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under D Dimer Testing Market?

D-dimer testing refers to laboratory blood testing that measures the d-dimer level in the bloodstream. D-dimer is a protein fragment produced when a blood clot breaks down in the body. The test is primarily used to help diagnose or rule out the presence of blood clots, particularly in conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE). The main types of tests in D-dimer testing are clinical laboratory tests and point-of-care tests. Clinical laboratory tests refer to a wide range of diagnostic procedures and analyses performed on patient samples in a laboratory setting. The various products include analyzers, reagents, and consumables. It includes various methods, such as enzyme-linked immunosorbent assay (ELISA), latex-enhanced immuno-turbidimetric assays, and others. These are used for several applications, including deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and others, and also by various end-users such as hospitals, academic and research institutes, diagnostic centers, and others.

What Is The D Dimer Testing Market Growth Forecast?

The d dimer testing market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growth of point-of-care diagnostics, increasing cardiovascular disease burden, technological advancements in immunoassays, faster turnaround demand, expansion of decentralized testing. Major trends in the forecast period include rising adoption of point-of-care testing, increased use in emergency diagnostics, expansion of automated laboratory analyzers, growth of rapid testing kits, integration into clinical decision protocols.

Global D Dimer Testing Market Segmentation

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests 2) By Product: Analyzers, Reagents And Consumables 3) By Method: Enzyme-Linked Immunosorbent Assay (ELISA), Latex-Enhanced Immuno-Turbidimetric Assays, Fluorescence Immunoassays, Other Testing Methods 4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications 5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-Users Subsegments: 1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays 2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays

What Is The Driver Of The D Dimer Testing Market?

The increasing prevalence of cancer is expected to propel the growth of the d-dimer testing market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. D-dimer testing is primarily used to help diagnose, monitor, and treat cancer patients and assess the risk of blood clot formation. It monitors thrombotic events in various clinical settings. For instance, in May 2025, according to the National Cancer Institute (NCI), a US-based government agency dedicated to cancer research and education, in 2025 an estimated 2,041,910 new cases of cancer will be diagnosed in the United States, and 618,120 people will die from the disease. Among men, prostate, lung, and colorectal cancers are expected to account for approximately 48% of all new cancer diagnoses, while among women, breast, lung, and colorectal cancers will account for about 51% of all new cases. In addition, an estimated 14,690 children and adolescents ages 0 to 19 will be diagnosed with cancer in 2025, with 1,650 expected to die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the d-dimer testing market.

Key Players In The Global D Dimer Testing Market

Major companies operating in the d dimer testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Global D Dimer Testing Market Trends and Insights

Major companies operating in the d-dimer testing market are developing innovative products, such as D-dimer test kit, to improve the accuracy and speed of diagnosing blood clot-related conditions. A D-dimer test kit is a medical diagnostic tool used to measure the levels of D-dimer, a fibrin degradation product, in the blood, which helps in assessing the presence of blood clots and conditions such as deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. For instance, in July 2024, Bionote Inc., a South Korea-based medical equipment manufacturing company launched Vcheck D-dimer 5Tests/Kit. A new D-dimer 5-Test Kit for Vcheck immunodiagnostic equipment has been launched, specifically designed for veterinary clinics. This kit aids in diagnosing conditions such as thrombosis and DIC, making it ideal for smaller clinics with fewer emergency cases.

What Are Latest Mergers And Acquisitions In The D Dimer Testing Market?

In March 2023, Werfen S.A., a Spain-based diagnostic company, acquired Immucor Inc. for $2 billion. Through this acquisition, Werfen aims to expand its product portfolio and strengthen its position in the global transfusion and transplantation diagnostics market to access Immucor's worldwide reach and resources. Immucor Inc. is a US-based manufacturer of d-dimer test kits, including enzyme-linked immunosorbent assay (ELISA), transfusion, and transplant diagnostic products.

Regional Outlook

North America was the largest region in the D dimer testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the D Dimer Testing Market?

The d-dimer testing market consists of revenues earned by entities by providing services such as sample collection, sample processing, exclusion of blood clots, and risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The d-dimer testing market also includes sales of d-dimer assay kits, d-dimer rapid tests, automated d-dimer analyzers, and point-of-care test kits that are used in providing d-dimer testing services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the D Dimer Testing Market Report 2026?

The d dimer testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the d dimer testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.